9.77
-0.37
(-3.68%)
At close: January 31 at 9:34:10 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-356,739.00
-394,086.00
-333,287.00
-225,030.00
-49,912.00
Investing Cash Flow
19,941.00
-31,347.00
160,309.00
-550,778.00
-214,487.00
Financing Cash Flow
289,914.00
130,323.00
582,955.00
736,688.00
371,779.00
End Cash Position
134,100.00
240,353.00
535,463.00
125,486.00
164,606.00
Capital Expenditure
-6,317.00
-13,985.00
-58,390.00
-12,756.00
-3,585.00
Issuance of Capital Stock
280,540.00
119,795.00
565,789.00
693,570.00
358,648.00
Free Cash Flow
-363,056.00
-408,071.00
-391,677.00
-237,786.00
-53,497.00
12/31/2020 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FYB.MU Formycon AG
54.70
+1.11%
1U5.SG Wave Life Sciences Ltd.
11.10
-3.48%
63E.MU Onward Medical NV
6.34
-6.49%
63E.BE Onward Medical NV
6.38
+0.31%
VVY.AS Vivoryon Therapeutics N.V.
2.0000
-0.50%
FYB.DE Formycon AG
53.60
-0.92%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
BMEA Biomea Fusion, Inc.
4.1800
-1.65%
DNLI Denali Therapeutics Inc.
23.30
-1.19%
TERN Terns Pharmaceuticals, Inc.
4.4600
-3.88%